Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Changes in Beneficial Ownership · 4

Insight Molecular Diagnostics Inc.

IMDXNASDAQEQUITYCurrent

Changes in Beneficial Ownership

Filed Nov 20, 2026Accepted Nov 20, 2026, 4:15 PM ESTFiling CIK 1642380Accession 0001493152-26-053495
Share

Structured filing — 4

ownership.xml

Open full document ↗

Filing details

Report period
2026-11-17
Issuer
Insight Molecular Diagnostics Inc.
Issuer CIK
0001642380
Trading symbol
IMDX

Reporting owner 1

Name
SMITH PATRICK W
Reporting owner CIK
0001167028
Relationship
10% owner
Address
C/O INSIGHT MOLECULAR DIAGNOSTICS INC., 2 INTERNATIONAL PLAZA, SUITE 510, NASHVILLE, TN, 37217

Non-derivative transactions

Non-derivative transactions · 1 reported row
SecurityTransaction dateCodeAmountA / DPrice (USD)Owned afterOwnershipNature of ownership
Common Stock2026-11-17J · Form 41,142,857[F1]A1.754,401,342ISee Footnote[F2]
Table key
J · Form 4
Other acquisition or disposition; see explanation
A
Acquired
I
Indirect

Footnotes

F1
Reflect shares of Insight Molecular Diagnostics Inc.'s (the "Issuer") common stock, no par value, purchased by the Reporting Person in an underwritten public offering of the Issuer at the public offering price of $1.75.↩ 1
F2
The shares of common stock reported herein are directly held by Patrick W Smith The Smith Irrevocable Trust U/A DTD 05/01/2015 (the "Trust"). As the trustee of the Trust, the Reporting Person may be deemed to beneficially own the securities held by the Trust.↩ 1

Signature 1

Signed
/s/ Patrick W. Smith
Date
2026-11-20

Company context

Current securities

Recent company filings

  1. 4 filingNov 19, 2026
  2. Entry into a Material Definitive Agreement · Other EventsNov 18, 2026
  3. 424B5 filingNov 18, 2026
  4. 424B5 filingNov 16, 2026
  5. Results of Operations and Financial ConditionNov 16, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.